Cite
Sensitive Detection of Minimal Residual Disease in Patients Treated for Early-Stage Breast Cancer.
MLA
Parsons, Heather A., et al. “Sensitive Detection of Minimal Residual Disease in Patients Treated for Early-Stage Breast Cancer.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 26, no. 11, June 2020, pp. 2556–64. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-19-3005.
APA
Parsons, H. A., Rhoades, J., Reed, S. C., Gydush, G., Ram, P., Exman, P., Xiong, K., Lo, C. C., Li, T., Fleharty, M., Kirkner, G. J., Rotem, D., Cohen, O., Yu, F., Fitarelli-Kiehl, M., Leong, K. W., Hughes, M. E., Rosenberg, S. M., Collins, L. C., … Adalsteinsson, V. A. (2020). Sensitive Detection of Minimal Residual Disease in Patients Treated for Early-Stage Breast Cancer. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 26(11), 2556–2564. https://doi.org/10.1158/1078-0432.CCR-19-3005
Chicago
Parsons, Heather A, Justin Rhoades, Sarah C Reed, Gregory Gydush, Priyanka Ram, Pedro Exman, Kan Xiong, et al. 2020. “Sensitive Detection of Minimal Residual Disease in Patients Treated for Early-Stage Breast Cancer.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 26 (11): 2556–64. doi:10.1158/1078-0432.CCR-19-3005.